Real asset investors should be aware of limitations


Investors interested in real assets should know the limitations of this asset class to better exploit growth potential, according to Zenith Investment Partners’ sector review.
The review found lower volatility that characterised real assets, which generally comprised private market (unlisted) investments, could create a paradox for unwary investors.
Dugald Higgins, Zenith’s head of real assets and listed strategies, said that reducing volatility was not the same as reducing risk.
“Risk should be viewed as permanent capital loss, not volatility. Structural aspects of real assets such as long investment timeframes, illiquidity and leverage, work to heighten complexities and risk at the individual fund level,” he said.
Aside from real assets fundamentals, one of the most powerful diversifying attributes was the low correlation to liquid assets. However, Higgins warned, a significant driver of this characteristic was low liquidity with fund liquidity generally mirroring that of the underlying assets.
“While sacrificing liquidity can be profitable, liquidity mismatch is inherent for vehicles that offer short-term redemptions while investing in long dated assets,” he added.
Over the 12 months to 31 October, 2019, Zenith’s universe of rated real assets funds returned an average of 10.65% p.a. over five years (net of fees) with an observed volatility of 3.6% p.a.
Recommended for you
Bentham Asset Management has become the latest fund manager to expand its distribution team as it reports increased interest in its credit strategies.
L1 Capital, which is in talks to merge with Platinum Asset Management, has indicated it will be voting against a deal to convert a Platinum LIC into an ETF.
Evidentia Group has hired a head of quantitative investments who joins the investment firm and managed account provider from AMP.
Fidelity International has worked in tandem with Australian wealth manager Emanuel Whybourne & Loehr to launch an actively managed global equities strategy aimed at financial advisers.